France· FR:62310080

CISPLATINE HIKMA 1 mg/mL, solution à diluer pour perfusion

A cisplatin product containing cisplatine, registered in France by HIKMA FARMACEUTICA (PORTUGAL). The same ATC class is registered in 16 of our 19 countries.

ATC L01XA01

Checked against Base de données publique des médicaments — BDPM (France) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cisplatineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cisplatin is registered in 16 of 19 countries.

Countries holding a registration under ATC L01XA01 (cisplatin), each read from that country’s own register.

This record: France, from Base de données publique des médicaments — BDPM (France)
8 of them publish a price we can compare per daily dose

Search cisplatin products by name

Cisplatin · ATC L01XA01

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)

Active substance: CISPLATINE
Manufacturer: HIKMA FARMACEUTICA (PORTUGAL)
Country: France (FR)
ATC code: L01XA01
ATC class: Cisplatin
Defined daily dose: 6.75 mg, P
Reimbursed: No
Source register: Base de données publique des médicaments — BDPM (France)
Last checked: September 12, 2026

Packs & prices · 2

cip13
3400955086741
1 flacon(s) en verre jaune(brun) de 50 ml
cip13
3400955086758
1 flacon(s) en verre jaune(brun) de 100 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

593 interactions on record for cisplatin.

Graded by severity as the source publishes them — 65 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cisplatin against other medicines How interaction checks work

Cisplatin · interactions on record

593 records

65 severe
252 moderate
20 minor
256 info

Most severe, free to view

AmiodaroneC01BD01severe
DofetilideC01BD04severe
DronedaroneC01BD07severe
EtelcalcetideH05BX04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cisplatin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cisplatin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Cisplatin Accord, Cisplatin Ebewe
Belgium · Cisplatin Accord Healthcare, Cisplatine Teva
Bulgaria · Цисплатин Акорд, Цисплатин Ебеве
Cyprus · Cisplatin Accord Healthcare, Cisplatin Pfizer Hellas
Czechia · Cisplatin Ebewe
Germany · Cisplatin Accord, Cisplatin Hikma
Denmark · Cisplatin "ebewe", Cisplatin Accord
Estonia · Cisplatin Accord
Spain · Cisplatino Accord, Cisplatino Hikma
Finland · Cisplatin Accord, Cisplatin Ebewe
United Kingdom (Northern Ireland) · Cisplatin, Cisplatin Accord Healthcare
Greece · Cisplatin Hospira, Oncoplat
Croatia · Cisplatin Pliva, Cisplatin Pontus
Hungary · Cisplatin Accord, Cisplatin Sandoz
Ireland · Cisplatin Accord Healthcare Ireland, Cisplatin Pfizer Healthcare Ireland
Italy · Cisplatin Teva, Cisplatino Accord Healthcare Italia
Lithuania · Cisplatin Accord
Luxembourg · Cisplatine Teva
Latvia · Cisplatin Accord
Malta · Cisplatin Accord Healthcare
Netherlands · Cisplatine Accord, Cisplatine Hikma
Norway · Cisplatin Accord
Poland · Cisplatin Ebewe, Cisplatinum Accord
Portugal · Cisplatina Accord, Cisplatina Hikma
Romania · Cisplatină Accord
Sweden · Cisplatin Accord, Cisplatin Ebewe
Slovenia · Cisplatin Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bfe8843e-30c3-4a0e-a910-586d4a7cd0e8
GET /v1/drugs/bfe8843e-30c3-4a0e-a910-586d4a7cd0e8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62310080",
  "date_amm": "2022-01-07",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "CISPLATINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

API reference MCP server Plans

See everything about cisplatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console